(Q39372948)

11 September 2017

title

Proposal of remission criteria for IgA nephropathy (English)

1 reference

11 September 2017

Yusuke Suzuki

1

1 reference

11 September 2017

Keiichi Matsuzaki

2

1 reference

11 September 2017

Hitoshi Suzuki

3

1 reference

11 September 2017

Naoko Sakamoto

4

1 reference

11 September 2017

Kensuke Joh

5

1 reference

11 September 2017

Tetsuya Kawamura

6

1 reference

11 September 2017

Yasuhiko Tomino

7

1 reference

11 September 2017

Seiichi Matsuo

8

1 reference

11 September 2017

publication date

4 August 2013

1 reference

Clinical and experimental nephrology

11 September 2017

published in

1 reference

11 September 2017

volume

18

1 reference

11 September 2017

issue

3

1 reference

11 September 2017

page(s)

481-486

1 reference

Corticosteroids in IgA nephropathy: a randomised controlled trial

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0849-X

Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0849-X

Predictors for progression in immunoglobulin A nephropathy with significant proteinuria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0849-X

Slower decline of glomerular filtration rate in the Japanese general population: a longitudinal 10-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0849-X

Proteinuria and the risk of developing end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0849-X

Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0849-X

A scoring system to predict renal outcome in IgA nephropathy: a nationwide 10-year prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0849-X

The natural history of immunoglobulin a nephropathy among patients with hematuria and minimal proteinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0849-X

Hong Kong study using valsartan in IgA nephropathy (HKVIN): a double-blind, randomized, placebo-controlled study

21 January 2018

1 reference

12 December 2020

Remission of proteinuria improves prognosis in IgA nephropathy

1 reference

12 December 2020

Natural history and prognostic factors of IgA nephropathy presented with isolated microscopic hematuria in Chinese patients

1 reference

12 December 2020

Complete remission within 2 years predicts a good prognosis after methylprednisolone pulse therapy in patients with IgA nephropathy

1 reference

12 December 2020

[Guidelines for the treatment of nephrotic syndrome]

1 reference

12 December 2020

[Guidelines for diagnosis of hematuria]

1 reference

12 December 2020

[Epidemiology and prognosis of IgA nephropathy]

1 reference

12 December 2020

Natural history and risk factors for immunoglobulin A nephropathy in Japan. Research Group on Progressive Renal Diseases

1 reference

12 December 2020

10.1007/S10157-013-0849-X

Identifiers

DOI

1 reference

11 September 2017

1 reference